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atrial fibrillation and flutter for thoracic surgical procedures. Executive
summaryA
CDGyorgy Frendl, MD, PhD, Alissa C. Sodickson, MD, Mina K. Chung, MD,
Albert L. Waldo, MD, PhD, Bernard J. Gersh, MB, ChB, DPhi, James E. Tisdale, PharmD,
Hugh Calkins, MD, Sary Aranki, MD, Tsuyoshi Kaneko, MD, Stephen Cassivi, MD,
Sidney C. Smith, Jr, MD, Dawood Darbar, MD, Jon O. Wee, MD,
Thomas K. Waddell, MD, MSc, PhD, David Amar, MD, and Dale Adler, MD, Boston,
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Nashville, Tenn; Toronto, Ontario, Canada; and New York, NYe153 2014 AATS guidelines for the prevention and management of perioperative
atrial fibrillation and flutter for thoracic surgical proceduresMPGyorgy Frendl, MD, PhD, Alissa C. Sodickson, MD, Mina K. Chung, MD,
Albert L. Waldo, MD, PhD, Bernard J. Gersh, MB, ChB, DPhi, James E. Tisdale, PharmD,
Hugh Calkins, MD, Sary Aranki, MD, Tsuyoshi Kaneko, MD, Stephen Cassivi, MD,
Sidney C. Smith, Jr, MD, Dawood Darbar, MD, Jon O. Wee, MD,
Thomas K. Waddell, MD, MSc, PhD, David Amar, MD, and Dale Adler, MD, Boston, Mass,
Cleveland, Ohio; Rochester, Minn; Indianapolis, Ind; Baltimore, Md; Chapel Hill, NC; Nashville,
Tenn; Toronto, Ontario, Canada; and New York, NYET
Congenital Heart
Disease (CHD)
792 Controlled reoxygenation during cardiopulmonary bypass decreases markers
of organ damage, inflammation, and oxidative stress in single-ventricle patients
undergoing pediatric heart surgery/B
SMassimo Caputo, MD, Amir Mokhtari, FRCS, Antonio Miceli, MD, Mohamed T. Ghorbel, PhD,
Gianni D. Angelini, FRCS, Andrew J. Parry, FRCS, and Saadeh M. Suleiman, DSc, Bristol,
United Kingdom, and Chicago, IllControlled reoxygenation CPB reduced the markers of organ damage, inflammation, and stress in
single-ventricle patients undergoing cardiac surgery.)
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TX810A The Journal of Thoracic an02 Long-term outcomes after definitive repair for tetralogy of Fallot with
preservation of the pulmonary valve annulus(continued on page 11A
d Cardiovascular Surgery c September 2014Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Yin Meng, MD, Heima Sakaguchi, MD,
Kenichi Kurosaki, MD, Isao Shiraishi, MD, PhD, Toshikatsu Yagihara, MD, and
Hajime Ichikawa, MD, PhD, Suita, JapanA total of 84 patients with TOF underwent definitive repair without right ventriculotomy and
preservation of the PVannulus from 1989 to 2000. During the mean follow-up period of 15.86 5.7
years, 1 late death and 3 reoperations occurred. Freedom from moderate or greater PR at 20 years
was 35.7%.810 Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients
after cardiac surgery
Sirisha Emani, PhD, Bethany Trainor, RN, David Zurakowski, PhD, Christopher W. Baird, MD,
Francis E. Fynn-Thompson, MD, Frank A. Pigula, MD, and Sitaram M. Emani, MD, Boston, MassAspirin therapy is administered to avoid thrombosis in high-risk patients but is rarely monitored.
We hypothesize that inadequate response to aspirin is associated with increased risk of thrombosis
after high-risk cardiac surgery. Our results suggest an association between aspirin unresponsiveness
and thrombosis.817 Surgical outcomes of 380 patients with double outlet right ventricle who
underwent biventricular repair
Shoujun Li, MD, Kai Ma, MD, PhD, Shengshou Hu, MD, Zhongdong Hua, MD, Keming Yang, MD,
Jun Yan, MD, and Qiuming Chen, MD, PhD, Beijing, People’s Republic of ChinaFrom 2005 to 2012, 380 consecutive patients with DORV underwent varied types of biventricular
repair at Fuwai Hospital. Surgical mortality, reoperations, and cardiac function were favorable,
even in those patients with a noncommitted VSD. Late-onset LVOTO was the main reason for
reoperation, but this can be successfully relieved.825 Twenty-five years’ experience of modified Lecompte procedure for the
anomalies of ventriculoarterial connection with ventricular septal defect and
pulmonary stenosis
Hong-Gook Lim, MD, PhD, Woong-Han Kim, MD, PhD, Jeong Ryul Lee, MD, PhD, and
Yong Jin Kim, MD, PhD, Seoul, Republic of KoreaThe modified Lecompte procedure creates a connection from the left ventricle to the aorta with
greater freedom from residual obstruction without an extracardiac valved conduit for treating
anomalies of ventriculoarterial connection with ventricular septal defect and pulmonary outflow
tract obstruction. The procedure has excellent long-term results with low mortality and morbidity.832 Mechanisms of tricuspid regurgitation in patients with hypoplastic left heart
syndrome undergoing tricuspid valvuloplasty
Victor Bautista-Hernandez, MD, PhD, David W. Brown, MD, Hugo Loyola, BSc,
Patrick O. Myers, MD, Michele Borisuk, RN, Pedro J. del Nido, MD, and
Christopher W. Baird, MD, Boston, MassIn patients with HLHS completing staged palliation, TR usually emanates from the AS commissure
and is associated with anterior leaflet prolapse and annular dilatation. Tricuspid valvuloplasty is
effective in improving TR and tricuspid dimensions at the first and repeat valvuloplasty.)
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841 The impact of hospital and surgeon volume on the 30-day mortality of lung
cancer surgery: A nation-based reappraisal(continued on page 12A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 3 11AH
DPierre-Emmanuel Falcoz, MD, PhD, Marc Puyraveau, MSc, Caroline Rivera, MD,
Alain Bernard, MD, PhD, Gilbert Massard, MD, PhD, Frederic Mauny, MD, PhD,
Marcel Dahan, MD, PhD, and Pascal-Alexandre Thomas, MD, PhD, on behalf of the Epithor Group,
Strasbourg, Besanc¸on, Bayonne, Dijon, Toulouse, and Marseille, FranceCSince 2007, when France’s first National Cancer Plan became effective, 30-day mortality of primary
lung cancer surgery has decreased and currently measures 3.8%. Low mortality was correlated with
higher surgeon volume but was not influenced by hospital volume.Commentary 848 Editorial comment
Benjamin D. Kozower, MD, MPH, Charlottesville, VaG
TS850 Transesophageal pulmonary nodule biopsy using endoscopic ultrasonography
Basil S. Nasir, MBBCh, Marcel Edwards, MD, Vicky Tiffault, RN, Jordan Kazakov, MD,
Mohammed Khereba, MD, Pasquale Ferraro, MD, and Moishe Liberman, MD, PhD, Montreal,
Quebec, CanadaA
CDEUS-FNA can be used to access perimediastinal parenchymal pulmonary nodules that are difficult
to reach using traditional methods. In the present study, EUS-FNA of parenchymal pulmonary
nodules has been shown to be safe and accurate and allows for biopsy of perimediastinal lung
lesions not attainable using traditional techniques.Acquired Cardiovascular
Disease (ACD)
856 Trends in use of off-pump coronary artery bypass grafting: Results from the
Society of Thoracic Surgeons Adult Cardiac Surgery DatabasePMFaisal G. Bakaeen, MD, A. Laurie W. Shroyer, PhD, James S. Gammie, MD, Joseph F. Sabik, MD,
Lorraine D. Cornwell, MD, Joseph S. Coselli, MD, Todd K. Rosengart, MD, Sean M. O’Brien, PhD,
AmeliaWallace, BSPH, David M. Shahian, MD, Frederick L. Grover, MD, and John D. Puskas, MD,
Houston, Tex, Stony Brook, NY, Baltimore, Md, Cleveland, Ohio, Durham, NC, Boston, Mass,
Aurora, Colo, and Atlanta, GaNo recent studies have examined the prevalence of off-pump coronary artery bypass grafting at a
national level. Our study analyzed recent trends in the use of off-pump versus on-pump coronary
artery bypass grafting operations and found that the proportion of off-pump procedures has
declined since 2002.8
T/65 Early and intermediate outcome after aortic valve replacement with a
sutureless bioprosthesis: Results of a multicenter studyB
SEAntonino S. Rubino, MD, Giuseppe Santarpino, MD, Herbert De Praetere, MD,
Keiichiro Kasama, MD, Magnus Dalen, MD, Ulrik Sartipy, MD, Jarmo Lahtinen, MD,
Jouni Heikkinen, MD, Wanda Deste, MD, Francesco Pollari, MD, Peter Svenarud, MD, PhD,
Bart Meuris, MD, PhD, Theodor Fischlein, MD, Carmelo Mignosa, MD, FECTS, and
Fausto Biancari, MD, PhD, Catania, Italy, Nuremberg, Germany, Leuven, Belgium, Stockholm,
Sweden, and Oulu, FinlandXTAVR with the sutureless Perceval S aortic valve bioprosthesis is associated with excellent early and
intermediate results. The benefits of this procedure are more evident in isolated AVR and in patients
with a high euroSCORE II.)
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TX812A The Journal of Thoracic an72 A quarter of a century of experience with aortic valve-sparing operations(continued on page 13A
d Cardiovascular Surgery c September 2014Tirone E. David, MD, Christopher M. Feindel, MD, Carolyn M. David, BN, and
Cedric Manlhiot, BSc, Toronto, Ontario, CanadaThe present prospective observational study on AVS operations demonstrated a freedom from
reoperation of 94.8% 6 2.0% and freedom from recurrent moderate or severe aortic insufficiency
of 78.0%6 4.8% at 18 years. Preoperative AI and the need for cusp repair had no adverse effect on
the long-term outcomes.881 Prediction of sinus rhythm in patients undergoing concomitant Cox maze
procedure through a median sternotomy
Niv Ad, MD, and Sari D. Holmes, PhD, Falls Church, VaEstablished clinical variables were used to develop prediction models for the success of the Cox
maze procedure for AF. The predictors of SR at 1 and 2 years postoperatively were identified. Our
study is the first step in establishing a reliable risk score to predict the outcomes after the Cox maze
procedure.888 Straight deep hypothermic circulatory arrest for cerebral protection during
aortic arch surgery: Safe and effective
Bulat A. Ziganshin, MD, Bijoy G. Rajbanshi, MD, Maryann Tranquilli, RN, Hai Fang, PhD, MPH,
John A. Rizzo, PhD, and John A. Elefteriades, MD, New Haven, Conn, Kazan, Russia, Kathmandu,
Nepal, Beijing, China, and Stony Brook, NYThe present study evaluated the use of DHCA for cerebral protection during aortic arch surgery in
490 consecutive patients. We found that up to 50 minutes of DHCA is safe and effective for cerebral
protection, accommodating the absolute majority of interventions involving the aortic arch.901 A randomized comparison of the Saphenous Vein Versus Right Internal
Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year
angiographic results and mid-term clinical outcomes
Ki-Bong Kim, MD, PhD, Ho Young Hwang, MD, PhD, Seokyung Hahn, PhD, Jun Sung Kim, MD,
and Se Jin Oh, MD, Seoul and Seongnam, KoreaThe SAVE RITA trial revealed that the SV composite grafts were noninferior to the RITA
composite grafts in terms of the 1-year angiographic patency rates.909 Residual and recurrent gradients after septal myectomy for hypertrophic
cardiomyopathy—mechanisms of obstruction and outcomes of reoperation
Yang Hyun Cho, MD, PhD, Eduard Quintana, MD, FETCS, Hartzell V. Schaff, MD,
Rick A. Nishimura, MD, Joseph A. Dearani, MD, Martin D. Abel, MD, and Steve Ommen, MD,
Rochester, Minn, Seoul, Korea, and Barcelona, SpainRepeat septal myectomy for recurrent LVOT obstruction provides excellent surgical results
regarding gradient relief and symptomatic improvement. The mechanisms of residual obstruction
will usually be related to the extent of the previous myectomy.)
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L917 Use of balloon expandable transcatheter valves for valve-in-valve implantation
in patients with degenerative stentless aortic bioprostheses: Technical
considerations and results(continued on page 14A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 3 13AH
DVinayak Bapat, FRCS, CTh, William Davies, FRCP, Rizwan Attia, MRCS, Jane Hancock, FRCP,
Kirsty Bolter, MSc, Christopher Young, FRCS, CTh, Simon Redwood, FRCP, and
Martyn Thomas, FRCP, London, United KingdomCTranscatheter valve-in-valve procedures can be used to treat failed stentless aortic bioprostheses.
The procedure is, however, challenging compared with that for stented bioprostheses.We report our
experience and discuss the key points necessary to achieve an optimal result when treating stentless
valves.925 Prognostic factors for aorta remodeling after thoracic endovascular aortic
repair of complicated chronic DeBakey IIIb aneurysmsTS
GSuk-Won Song, MD, PhD, Tae Hoon Kim, MD, Sun-Hee Lim, RN, Kwang-Hun Lee, MD, PhD,
Kyung-Jong Yoo, MD, PhD, and Bum-Koo Cho, MD, PhD, Seoul, Republic of KoreaControversy surrounds TEVAR for CDIIIb aneurysms. Although reentry tears above the celiac
trunk were fully covered, the visceral branches and intercostal arteries from the FL and all channels
below the celiac trunk kept the FL pressurized and were unfavorable prognostic factors for aorta
remodeling.9C34 Aortic valve reconstruction using autologous pericardium for patients aged less
than 60 yearsD
AShigeyuki Ozaki, MD, PhD, Isamu Kawase, MD, PhD, Hiromasa Yamashita, MD,
Yukinari Nozawa, MD, Mikio Takatoh, MD, So Hagiwara, MD, and Nagaki Kiyohara, MD,
Tokyo, JapanWe report the feasibility of our original aortic valve reconstruction using glutaraldehyde-treated
autologous pericardium for younger patients. Midterm results were excellent with no calcification
of the pericardial cusps. Postoperative hemodynamics were excellent. Patients can have a good
quality of life without any anticoagulation postoperatively.M939 Effectiveness of biatrial epicardial application of amiodarone-releasing
adhesive hydrogel to prevent postoperative atrial fibrillationPXiao Dong Feng, MD, Xue NingWang, MD, PhD, Xin Hiu Yuan, MD, andWilliamWang, MD, PhD,
Shanghai, TaiYuan, and Changzhi, China; and La Jolla, CalifB
SWe report a biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent
POAF. It is a less invasive, well-tolerated, quick, and effective therapeutic option for preventing
POAF at minimal risk of extracardiac adverse side effects. /
944 Modeling of predissection aortic size in acute type A dissection: More than
90% fail to meet the guidelines for elective ascending replacementETBartosz Rylski, MD, Emanuela Branchetti, PhD, Joseph E. Bavaria, MD,
Prashanth Vallabhajosyula, MD, Wilson Y. Szeto, MD, Rita K. Milewski, MD, PhD, and
Nimesh D. Desai, MD, PhD, Philadelphia, Pa, and Freiburg, GermanyTXThe present investigation evaluated the incidence of predissection ascending aortic dilatation in the
acute type A dissection population. More than 60% of patients will have a nondilated ascending
aorta before dissection onset. Only 3% would meet the criteria for elective ascending replacement
to prevent aortic dissection.)
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TX914A The Journal of Thoracic an49 Acute type A aortic dissection extending beyond ascending aorta: Limited or
extensive distal repair(continued on page 15A
d Cardiovascular Surgery c September 2014Bartosz Rylski, MD, Friedhelm Beyersdorf, MD, PhD, Fabian A. Kari, MD, Julia Schlosser, BS,
Philipp Blanke, MD, and Matthias Siepe, MD, Freiburg and W€urzburg, GermanyComplex aortic arch surgery in the setting of acute type A aortic dissection has been associated with
high in-hospital mortality. Limiting the surgery to ascending aortic replacement resulted in low
perioperative mortality. Thus, aortic arch repair can be deferred, because it can be performed
electively with a lower mortality risk.955 Aminimally invasive Coxmaze IV procedure is as effective as sternotomywhile
decreasing major morbidity and hospital stay
Christopher P. Lawrance, MD, Matthew C. Henn, MD, Jacob R. Miller, MD,
Laurie A. Sinn, RN, BSN, Richard B. Schuessler, PhD, Hersh S. Maniar, MD, and
Ralph J. Damiano, Jr, MD, St Louis, MoA single-center, retrospective review of 356 patients shows that the Cox maze IV procedure
performed through a right minithoracotomy is as effective as sternotomy in the treatment of atrial
fibrillation with decreasedmorbidity, mortality, length of stay in the intensive care unit, and hospital
length of stay.963 Frozen elephant trunk with total arch replacement for type A aortic
dissections: Does acuity affect operative mortality?
Wei-Guo Ma, MD, Jun Zheng, MD, Wei Zhang, MD, Kai Sun, MD, PhD, Bulat A. Ziganshin, MD,
Long-Fei Wang, MD, Rui-Dong Qi, MD, Yong-Min Liu, MD, Jun-Ming Zhu, MD, Qian Chang, MD,
John A. Elefteriades, MD, and Li-Zhong Sun, MD, Beijing, China, and New Haven, ConnIn 803 patients with type A dissection undergoing frozen elephant trunk with total arch replacement
(the Sun procedure), acuity was not a risk factor for operative mortality. However, previous
cerebrovascular disease; malperfusion of the brain, kidneys, spinal cord, and/or viscera;
extra-anatomic bypass; and longer cardiopulmonary bypass time increased the risk of mortality.973 When does transapical aortic valve replacement become a futile procedure? An
analysis from a national registry
Augusto D’Onofrio, MD, PhD, Stefano Salizzoni, MD, PhD, Marco Agrifoglio, MD, PhD,
Vincenzo Lucchetti, MD, Francesco Musumeci, MD, Giampiero Esposito, MD,
Paolo Magagna, MD, Marco Aiello, MD, Carlo Savini, MD, Mauro Cassese, MD,
Mattia Glauber, MD, Giuseppe Punta, MD, Ottavio Alfieri, MD, Davide Gabbieri, MD,
Domenico Mangino, MD, Andrea Agostinelli, MD, PhD, Ugolino Livi, MD,
Omar Di Gregorio, MD, Alessandro Minati, MD, Giuseppe Faggian, MD, Claudia Filippini, BSc,
Mauro Rinaldi, MD, and Gino Gerosa, MD, Padova, Torino, Milano, Mercogliano, Roma,
Bergamo, Rozzano, Vicenza, Pavia, Bologna, Bari, Massa, Modena, Mestre, Parma, Udine, Cuneo,
Trieste, and Verona, ItalyA multicenter retrospective study on 645 patients undergoing transapical TAVR was performed to
identify predictors of futility, defined as mortality within 1 year after a successful operation.
Patients with preoperative insulin-dependent diabetes, advanced chronic kidney disease, rhythm
disorders, and low LVEF have a higher risk to undergo futile procedures.)
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L981 Residual patient, anatomic, and surgical obstacles in treating active left-sided
infective endocarditis(continued on page 16A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 3 15ASyed T. Hussain, MD, Nabin K. Shrestha, MD, Steven M. Gordon, MD, Penny L. Houghtaling, MS,
Eugene H. Blackstone, MD, and G€osta B. Pettersson, MD, PhD, Cleveland, OhioH
DCDuring the past decade, we have had lower hospital mortality for surgically treated left-sided IE and
have neutralized the added risk of PVE. However, invasive endocarditis involving the mitral valve,
whether native or prosthetic, remains a risk factor, related to residual patient, anatomic, and surgical
obstacles.989 Homograft use in reoperative aortic root and proximal aortic surgery for
endocarditis: A 12-year experience in high-risk patientsTSOurania Preventza, MD, Ahmed S. Mohamed, MD, Denton A. Cooley, MD, Victor Rodriguez, MD,
Faisal G. Bakaeen, MD, Lorraine D. Cornwell, MD, Shuab Omer, MD, and Joseph S. Coselli, MD,
Houston, TexGComplex aortic root reconstruction with a homograft for active endocarditis, specifically after
previous repair of the root and ascending aorta, can be challenging. Our 12-year experience with
these complex procedures shows that homograft root implantation is associated with acceptable
early and midterm survival and a low risk of reinfection.995 Mitral valve repair rates correlate with surgeon and institutional experienceD
A
CDamien J. LaPar, MD, MSc, Gorav Ailawadi, MD, James M. Isbell, MD, MSCI,
Ivan K. Crosby, MD, John A. Kern, MD, Jeffrey B. Rich, MD, Alan M. Speir, MD, and
Irving L. Kron, MD, Investigators for the Virginia Cardiac Surgery Quality Initiative,
Charlottesville, Norfolk, and Falls Church, VaThe results of the present study have demonstrated that the average annual surgeon and hospital
volume are significantly associated with the propensity forMV repair performance overMVR, with
an increased likelihood for repair among surgeons performing .20 procedures annually.1P005 Pulmonary endarterectomy for distal chronic thromboembolic pulmonary
hypertensionMAndrea M. D’Armini, MD, Marco Morsolini, MD, PhD, Gabriella Mattiucci, MD,
Valentina Grazioli, MD, Maurizio Pin, MD, Adele Valentini, MD, Giuseppe Silvaggio, MD,
Catherine Klersy, MD, MSc, and Roberto Dore, MD, Pavia, Italy/B
SMany patients are still diagnosed with inoperable CTEPH. The number of pulmonary
endarterectomies for distal CTEPH increased significantly over time, and despite that this
represents the most challenging situation, postoperative outcomes are excellent. The diagnosis of
inoperable CTEPH should be achieved only in experienced centers with higher operability rates.
T1013 Long-term outcomes after immediate aortic repair for acute type A aortic
dissection complicated by comaETakuro Tsukube, MD, PhD, Tomonori Haraguchi, MD, PhD, Yasushi Okada, MD,
Ritsu Matsukawa, MD, PhD, Shuichi Kozawa, MD, PhD, Kyoichi Ogawa, MD, PhD, and
Yutaka Okita, MD, PhD, Kobe, JapanTXImmediate aortic repair was performed in 24 patients with acute type A aortic dissection
complicated by coma. Full recovery of consciousness and activities of daily living independence
were achieved in 79% and 50%, respectively, and the cumulative survival was 48.2% after 10 years.
Early and long-term neurologic outcomes after the strategy were satisfactory.)
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TX116A The Journal of Thoracic an020 Management of mitral regurgitation in Marfan syndrome: Outcomes of valve
repair versus replacement and comparison with myxomatous mitral valve
disease(continued on page 17A
d Cardiovascular Surgery c September 2014Meghana R. K. Helder, MD, Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Zhuo Li, MS,
John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, and Heidi M. Connolly, MD, Rochester, MinnMitral valve repair in patients with Marfan syndrome and mitral regurgitation confers a survival
advantage over mitral valve replacement. Survival and cumulative late risk of reoperation were
comparable to those of a case-matched patient population with myxomatous mitral valve disease
undergoing valve repair.1025 Is it possible to assess the best mitral valve repair in the individual patient?
Preliminary results of a finite element study from magnetic resonance imaging
data
Francesco Sturla, MSc, Francesco Onorati, MD, PhD, Emiliano Votta, PhD,
Konstantinos Pechlivanidis, MD, Marco Stevanella, PhD, Aldo D. Milano, MD,
Giovanni Puppini, MD, Alessandro Mazzucco, MD, Alberto Redaelli, PhD, and
Giuseppe Faggian, MD, Verona and Milan, ItalyFinite element analysis was used to quantitatively compare, on a patient-specific basis, the
biomechanical effects of a broad spectrum of different neochordal implantation techniques for the
repair of mitral posterior leaflet prolapse. Systematic biomechanical differences between
neochordal techniques were found, potentially affecting clinical outcomes.Perioperative
Management (PM)
1035 Topical vancomycin in combination with perioperative antibiotics and tight
glycemic control helps to eliminate sternal wound infections
Harold L. Lazar, MD, Ara Ketchedjian, MD, Miguel Haime, MD, Karl Karlson, MD, and
Howard Cabral, PhD, Boston, MassTopical vancomycin applied to the sternal edges, in conjunction with perioperative antibiotics and
tight glycemic control, helps to eliminate sternal would infections in cardiac surgical patients.Evolving Technology/
Basic Science (ET/BS)
1041 A paired membrane umbrella double-lumen cannula ensures consistent
cavopulmonary assistance in a Fontan sheep model
Dongfang Wang, MD, PhD, Guodong Gao, MD, Mark Plunkett, MD, Guangfeng Zhao, PhD,
Stephen Topaz, BS, Cherry Ballard-Croft, PhD, and Joseph B. Zwischenberger, MD, Lexington, KyAnewcavopulmonary assist double-lumen cannulawith pairedmembrane umbrellaswas tested in an
effective cavopulmonary connection mock loop and adult sheep model. Our double-lumen cannula
provided consistent cavopulmonary support despite cannula rotation or displacement. Therefore, our
double-lumen cannula does not require strict alignment for effective cavopulmonary assistance.1048 Metabolic syndrome impairs notch signaling and promotes apoptosis in
chronically ischemic myocardium
Nassrene Y. Elmadhun, MD, Ashraf A. Sabe, MD, Antonio D. Lassaletta, MD, Louis M. Chu, MD,
Katelyn Kondra, BS, Michael Sturek, PhD, and Frank W. Sellke, MD, Providence, RI, and
Indianapolis, IndIn a swine model of early MetS and chronic myocardial ischemia, MetS significantly impaired
notch and angiogenesis signaling, increased apoptosis signaling, decreased survival signaling, and
increased cell death in chronically ischemic myocardium. These findings suggest that MetS might
impair long-term myocardial angiogenesis through notch and apoptosis signaling.)
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L1056 Circulating tumor cells from a 4-dimensional lung cancer model are
resistant to cisplatin(continued on page 18A
The Journal of Thoracic and Cardiovascular Surgery c Volume 148, Number 3 17AMonika Vishnoi, PhD, Dhruva K. Mishra, PhD, Michael J. Thrall, MD, Jonathan M. Kurie, MD,
and Min P. Kim, MD, FACS, Houston, TexD
CHThe 4D lung cancer model allows for the isolation of circulating tumor cells that are resistant to
cisplatin treatment. Moreover, the treatment of tumor nodules in the 4D lung cancer model leads to a
decrease in tumornodule size and an increase in the numberofCTCsandMMP-2 levels per tumorarea.1065 Safety and efficacy of high-dose adeno-associated virus 9 encoding
sarcoplasmic reticulum Ca21 adenosine triphosphatase delivered by
molecular cardiac surgery with recirculating delivery in ovine ischemic
cardiomyopathyG
TSMichael G. Katz, MD, PhD, Anthony S. Fargnoli, MS, Richard D. Williams, BS,
Nury M. Steuerwald, PhD, Alice Isidro, PA-C, Anna V. Ivanina, PhD, Inna M. Sokolova, PhD, and
Charles R. Bridges, MD, ScD, Charlotte, NCCardiac overexpression of the SERCA2a gene using MCARD is a safe and efficient therapeutic
intervention. It significantly improves LV function, decreases markers of oxidative stress, arrests
remodeling, abrogatesmyocyte hypertrophy, and doesnot induce aT-cell–mediated immune response.1074 Quantitative analysis of exhaled carbonyl compounds distinguishes benign
from malignant pulmonary diseaseD
A
CMichael Bousamra II, MD, Erin Schumer, MS, MD, Mingxiao Li, PhD, Ralph J. Knipp, MS,
Michael H. Nantz, PhD, Victor van Berkel, MD, PhD, and Xiao-An Fu, PhD, Louisville, KyBreath analysis for lung cancer is a promising noninvasive diagnostic method. We present the
identification and analysis of 4 specific volatile carbonyl compounds to differentiate benign
pulmonary disease from early-stage lung cancer. Judicious use of these cancer markers may
expedite the management of potential lung cancer.1082 Energy loss, a novel biomechanical parameter, correlates with aortic aneurysm
size and histopathologic findingsPMJennifer Chung, MD, Kevin Lachapelle, MD, Evan Wener, BASc, Raymond Cartier, MD,
Benoit De Varennes, MD, Richard Fraser, MD, MSc, and Richard L. Leask, PhD, Montreal,
Quebec, CanadaEnergy loss is a biomechanical parameter describing the relative amount of energy absorbed by the
aorta during the cardiac cycle. It correlates significantly with aortic size and can separate aortas of
the same size according to the histopathologic findings.1
T/090 Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly
revascularizes ischemic myocardium and preserves ventricular function
B
SEPavan Atluri, MD, Jordan S. Miller, PhD, Robert J. Emery, MS, George Hung, BA,
Alen Trubelja, BS, Jeffrey E. Cohen, MD, Kelsey Lloyd, BS, Jason Han, BS, Ann C. Gaffey, MD,
John W. MacArthur, MD, Christopher S. Chen, MD, PhD, and Y. Joseph Woo, MD, Philadelphia,
Pa, Houston, Tex, Boston, Mass, and Stanford, CalifTXEndothelial progenitor cell injection has demonstrated limited improvements in myocardial
function in clinical trials. Cell dispersal and limited engraftment markedly reduce the overall
potential of this therapy. Novel, tissue-engineered endothelial progenitor cell-fibrin hydrogel
constructs can overcome these limitations by enhancing cell engraftment, vasculogenesis, and
hemodynamic function.)
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118A The Journal of Thoracic an099 An easily calculable and highly predictive risk index for postoperative renal
failure after heart transplantation(continued on page 19A
d Cardiovascular Surgery c September 2014Arman Kilic, MD, Joshua C. Grimm, MD, Ashish S. Shah, MD, John V. Conte, MD,
Glenn J. R. Whitman, MD, and Christopher M. Sciortino, MD, PhD, Baltimore, MdThis study derived and validated a composite score for new-onset postoperative renal failure after
adult heart transplantation. Risk categories were generated using probabilities determined in the
derivation cohort. Prospective assessment of heart transplant recipients using the risk index and
associated risk categories may be helpful in tailoring perioperative management.1106 Genetically engineered pigs and target-specific immunomodulation provide
significant graft survival and hope for clinical cardiac xenotransplantation
Muhammad M. Mohiuddin, MD, Avneesh K. Singh, PhD, Philip C. Corcoran, MD,
Robert F. Hoyt, DVM, Marvin L. Thomas III, DVM, David Ayares, PhD, and Keith A. Horvath, MD,
Bethesda and Frederick, Md; and Blacksburg, VaXenotransplantation can solve the problem of organ shortage. We have shown that, by using hearts
from genetically engineered pigs and with target-specific immunosuppression of the recipient
baboon, heterotopic xenograft survival can be significantly prolonged. Similar results in a
life-sustaining orthotopic model may pave the way for clinical xenotransplantation.1115 Outcomes after implantation of partial-support left ventricular assist devices in
inotropic-dependent patients: Do we still need full-support assist devices?
Anton Sabashnikov, MD, Aron-Frederik Popov, MD, PhD, Christopher T. Bowles, PhD,
Prashant N. Mohite, MCh, Alexander Weymann, MD, PhD, Rachel Hards, BS, Mike Hedger, BS,
Thorsten Wittwer, MD, PhD, Jens Wippermann, MD, PhD, Thorsten Wahlers, MD, PhD,
Friedrich A. Schoendube, MD, PhD, and Andre R. Simon, MD, PhD, Harefield, United Kingdom;
and Cologne and Goettingen, GermanyThe Synergy Pocket Micro-pump (HeartWare Inc, Framingham, Mass) is the smallest surgically
implanted long-term LVAD, which was primarily designed for less sick patients with severe heart
failure.We present our experiencewith implementation of long-term partial circulatory support as a
bridge to transplantation in patients with more advanced heart failure who were dependent
preoperatively on inotropic support or intra-aortic balloon pump. Our preliminary results show that
partial-support devices may have the potential to replace full-support LVADs in the near future.1123 Functional evaluation of human donation after cardiac death donor hearts
using a continuous isolated myocardial perfusion technique: Potential for
expansion of the cardiac donor population
Satoru Osaki, MD, PhD, Matthew R. Locher, PhD, Entela B. Lushaj, MD, PhD,
Shahab A. Akhter, MD, and Takushi Kohmoto, MD, PhD, Madison, WisThis study investigated resuscitation potential and acute contractile function in adult human DCD
hearts by ex vivo perfusion. Resuscitation potential in DCD hearts was achievedwhenWITwas less
than 40 minutes. Contractile performance in DCD hearts tended to be lower compared with BD
hearts.)
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DCell survival after transplantation is still a major obstacle for cell-based therapy. We found that
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